[1]
Muhammad Murtaza Shafqat, Ali Raza Naqvi, Amir Shafique, Rashid Ali Khosa, Shabeer Ahmed, Hazar Khan Bugti 2022. Ryzodeg (Insulin Degludec/Aspart) for Type 2 Diabetes in Pakistan: A 12-Week Study on Glycemic Control and Safety Outcomes. Pakistan Journal of Medical & Health Sciences. 16, 09 (Sep. 2022), 1003. DOI:https://doi.org/10.53350/pjmhs221691003.